O4 Research was responsible for the UK arm of a global Phase III placebo-controlled Shingles vaccine study in subjects 50 years and older which required a significant 80 plus cohort.
We pride ourselves on our innovative and comprehensive approach to study design and delivery which led to study award by the Sponsor. Our contribution to the study was multifaceted and we were responsible for investigator site identification and selection, implementing our unique community wide marketing strategy and providing project and site management excellence.
With every clinical trial comes challenges, and this study was no different. This study experienced many delays prior to study kick-off for a number of reasons. We overcame these challenges by putting into practice our ability to communicate effectively with our sites. Keeping them informed meant that site staff were always motivated to recruit and were capable of hitting the ground running when required.
Strong communication is a hallmark of O4 research and we advocate this to everyone involved, encouraging transparency throughout all stages of each study. Our passion for clinical research and continuous progress in this field translates to embracing our clients’ studies as if they are our own, cultivating an environment which facilitates a holistic study process which we believe is integral to study success.